The Brigham and Dana-Farber Board Review and Hematology and Oncology Board Review 2022 uses case-based learning to improve your knowledge and clinical competency. Keep up with the current board exam material and master core ideas, shifting guidelines, and effective therapy practices. Continuing medical education emphasizes practice improvement:
- Adult/Congenital Bone Marrow Failure
- Thalassemia/Hemoglobinopathies
- Transfusion Medicine
- Great Pharmacology Advances
- Poor immune system infections Cancers of the blood (leukemias, myelomas)
- Thoracic oncology, comprising head, neck, lung, and thyroid disorders.
Learning Objectives of Hematology and Oncology Board Review 2022:
After Hematology and Oncology Board Review 2022, participants can:
- Use the latest hematology and oncology recommendations in your practice.
- Analyze complex hematologic and oncologic cases.
- Explore and use cutting-edge hematologic and oncologic treatments.
- Hematology and oncology clinical literature analysis and interpretation.
- Understand pathophysiology for hematology and oncology treatment.
- Apply knowledge to ABIM hematology and oncology certification/recertification exams after Hematology and Oncology Board Review 2022.
Audience Target:
Hematology and oncology specialists and other medical experts interested in the field were invited to the event. The event included board test preparation and ongoing medical education to improve hematology and cancer patient care.
TOPICS / SPEAKERS of Hematology and Oncology Board Review 2022:
- Molecular Genetics of Cancer –Â Nikhil Wagle, MD
- Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents – Geoffrey I. Shapiro, MD, PhD
- Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment – Geoffrey I. Shapiro, MD, PhD
- Infections in Cancer Patients –Â Lindsey Baden, MD
- Symptom Management in Patients with Cancer –Â Andrew J. Lawton, MD
- Communication: The Key to Excellence in End-of-Life Care –Â Rachelle E. Bernacki, MD, MS, FAAHPM, AGSF
- Biology of Hematopoietic Stem Cell Transplantation –Â Robert J. Soiffer, MD
- Biology of Acute Leukemia and Myelodysplastic Syndromes –Â Benjamin L. Ebert, MD, PhD
- Acute Leukemias –Â Daniel J. DeAngelo, MD, PhD
- Myelodysplastic Syndrome –Â Eric S. Winer, MD
- Chronic Myelogenous Leukemia –Â Marlise R. Luskin, MD
- Myeloproliferative Syndromes –Â Ann M. Mullally, MD
- Multiple Myeloma –Â Kenneth C. Anderson, MD
- Waldenstrom Macroglobulinemia and Amyloidosis –Â Jorge J. Castillo, MD
- Low-Grade Lymphomas –Â Caron A. Jacobson, MD
- Aggressive Non-Hodgkin Lymphoma –Â Eric D. Jacobsen, MD
- Hodgkin’s Lymphoma –Â Reid W. Merryman, MD
- Diagnosis and Treatment of CLL and Related B Cell Malignancies –Â Matthew S. Davids, MD
- Head and Neck Cancer –Â Robert I. Haddad, MD
- Natural History, Screening, and Small Cell Lung Cancer –Â Bruce E. Johnson, MD
- Management of Stage I-III Non-Small Cell Lung Cancer –Â Mark Awad, MD, PhD
- Management of Metastatic Non-Small Cell Lung Cancer –Â Mark Awad, MD, PhD
- Mesothelioma and Thymoma –Â David M. Jackman, MD
- Carcinoid and Neuroendocrine Tumors –Â Jennifer Ang Chan, MD
- Novel Approaches for the Management of Esophageal and Gastric Cancers –Â Peter C. Enzinger, MD
- Pancreatic Cancer –Â Brian M. Wolpin, MD
- Hepatobiliary Cancer –Â James M. Cleary, MD, PhD
- Anal Cancer & Colorectal Cancers Part 1 –Â Robert J. Mayer, MD
- Colorectal Cancers Part 2 –Â Robert J. Mayer, MD
- Gastrointestinal Cancer: Genetic Syndromes –Â Matthew Yurgelun, MD
- Testicular Cancer –Â Mark M. Pomerantz, MD
- Renal and Bladder Cancer –Â Guru P. Sonpavde, MBBS
- Prostate Cancer Part I: Overview and Management of Localized Disease –Â Atish D. Choudhury, MD, PhD
- Prostate Cancer Part II: Management of Disseminated Prostate Cancer –Â Atish D. Choudhury, MD, PhD
- Melanoma –Â F. Stephen Hodi, MD
- Sarcomas and Gastrointestinal Stromal Tumors (GIST) –Â Suzanne George, MD
- Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer –Â Ursula A. Matulonis, MD
- Cervical and Endometrial Cancer –Â Panagiotis A. Konstantinopoulos, MD, PhD
- Neuro-oncology –Â David A. Reardon, MD
- Breast Cancer – Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH
- Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
- Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
- Management of Metastatic Breast Cancer –Â Adrienne G. Waks, MD
- Breast Cancer Survivorship –Â Ann H. Partridge, MD, MPH
- Hematopoiesis and Cytokines –Â David T. Scadden, MD
- Acquired Bone Marrow Failure –Â Julie-Aurore Losman, MD, PhD
- Congenital Bone Marrow Failure –Â Akiko Shimamura, MD, PhD
- Hemophagocytic Syndromes and Related Immunodeficiencies –Â Barbara A. Degar, MD
- Anemia – An Overview – Robert Stern, MD
- Iron Deficiency and Iron Overload –Â Mark D. Fleming, MD, PhD
- Immune Hemolytic Anemia –Â Richard M. Kaufman, MD
- Non-immune Hemolytic Anemia –Â David E. Golan, PhD, MD
- Sickle Cell Disease –Â Maureen M. Achebe, MD, MPH
- Thalassemia and Other Hemoglobinopathies –Â Matthew M. Heeney, MD
- Disorders of Neutrophils –Â Nancy Berliner, MD
- Acquired Thrombocytopenias –Â Elisabeth M. Battinelli, MD, PhD
- Hemophilia –Â Aric D. Parnes, MD
- Von Willebrand Disease and Congenital Platelet Disorders –Â Nathan T. Connell, MD, MPH
- Congenital and Acquired Thrombophilia –Â Kenneth A. Bauer, MD
- Use of Direct Oral Anticoagulants in Clinical Practice –Â Jean M. Connors, MD
- Transfusion Medicine for the Clinician –Â Walter H. Dzik, MD
See Also: Hematology with 2023 Highlights of ASH in North America
Reviews
There are no reviews yet.